3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 1
6
Phase 1/2
2
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
45
Prostatic Neoplasms
41
Brain Neoplasms
27
Lung Neoplasms
19
Glioblastoma
17
Glioma
16
Neoplasms
13
Neoplasm Metastasis
13
Carcinoma, Non-Small-Cell Lung
13
Head and Neck Neoplasms
10
Pancreatic Neoplasms
8
Central Nervous System Neoplasms
8
Uterine Cervical Neoplasms
7
Lymphoma
7
Carcinoma, Hepatocellular
7
Rectal Neoplasms
6
Oligodendroglioma
6
Gliosarcoma
6
Carcinoma, Squamous Cell
6
Astrocytoma
6
Squamous Cell Carcinoma of Head and Neck
5
Esophageal Neoplasms
5
Ependymoma
5
Colorectal Neoplasms
5
Carcinoma, Renal Cell
5
Carcinoma, Intraductal, Noninfiltrating
5
Sarcoma
4
Meningioma
4
Colonic Neoplasms
4
Breast Neoplasms, Male
4
Interventions
fludarabine
2
Cyclophosphamide
2
zanubrutinib
1
pegfilgrastim
1
obinutuzumab
1
fludarabine phosphate
1
Specimen Handling
1
Resistance Training
1
Radiotherapy
1
Neuropsychological Tests
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Injections
1
Filgrastim
1
Contrast Media
1
Blood Specimen Collection
1
Azacitidine
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, B-Cell
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled